- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Edesa Biotech (EDSA)
Company Profile
| Quarter (USD) | Jun 25 | Mar 25 | Dec 24 | Sep 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 12.36 mm | 12.36 mm | 12.36 mm | 12.36 mm | 12.36 mm | 12.36 mm |
| Cash burn (monthly) | 511.65 k | (no burn) | 634.58 k | 537.14 k | 566.92 k | 547.36 k |
| Cash used (since last report) | 2.78 mm | n/a | 3.44 mm | 2.91 mm | 3.08 mm | 2.97 mm |
| Cash remaining | 9.59 mm | n/a | 8.92 mm | 9.45 mm | 9.29 mm | 9.39 mm |
| Runway (months of cash) | 18.7 | n/a | 14.1 | 17.6 | 16.4 | 17.2 |
| 13F holders | Current |
|---|---|
| Total holders | 19 |
| Opened positions | 10 |
| Closed positions | 4 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 357.92 mm |
| Total shares | 4.91 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Pardeep Nijhawan Medicine Professional | 2.59 mm | $2.28 mm |
| Lumira Capital Investment Management | 1.75 mm | $4.37 mm |
| Nijhawan Pardeep | 360.59 k | $1.15 mm |
| CM Management | 110.00 k | $184.80 mm |
| Citadel Advisors | 40.94 k | $69.61 mm |
| Geode Capital Management | 19.80 k | $33.67 mm |
| Vanguard | 15.86 k | $26.97 mm |
| Two Sigma Securities | 15.31 k | $25.73 mm |
| Tower Research Capital | 3.44 k | $5.78 mm |
| RY Royal Bank of Canada | 1.82 k | $3.00 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Dec 25 | Nijhawan Pardeep | Common Shares | Grant | Acquire A | No | No | 0 | 8,766 | 0.00 | 491,378 |
| 3 Nov 25 | Nijhawan Pardeep | Common Shares | Grant | Acquire A | No | No | 0 | 6,968 | 0.00 | 482,612 |
| 2 Oct 25 | Nijhawan Pardeep | Common Shares | Grant | Acquire A | No | No | 0 | 5,908 | 0.00 | 475,644 |
| 11 Sep 25 | Nijhawan Pardeep | Common Shares | Grant | Acquire A | No | No | 0 | 5,981 | 0.00 | 469,736 |
| 1 Aug 25 | Nijhawan Pardeep | Common Shares | Grant | Acquire A | No | No | 0 | 6,802 | 0.00 | 463,755 |